Lars Holten-Andersen,Vibeke Miller Breinholt,Kennett Sprogøe
申请号：
US16338185
公开号：
US20200276270A1
申请日:
2017.09.28
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a combination of a CNP agonist and at least one further biologically active moiety or drug for use in a method for the treatment or prevention of disorders that benefit from stimulating growth, pharmaceutical compositions comprising at least one CNP agonist, preferably controlled-release CNP agonist, wherein the pharmaceutical composition comprises at least one further biologically active moiety or drug, to using these pharmaceutical compositions as a medicament, to their use in the treatment of disorders that benefit from stimulating growth and to methods of preventing or treating a patient having a disorder that benefits from stimulating growth.
